Understanding CLL/SLL Treatments: Fixed and Continuous-Duration Therapy Guide image

Understanding CLL/SLL Treatments: Fixed and Continuous-Duration Therapy Guide

Posted by
HealthTree image
HealthTree
Last updated and reviewed on: May 27, 2026
The purpose of this guide is to assist people with CLL/SLL and their caregivers in understanding fixed and continuous-duration therapies used in CLL/SLL treatment. Developed independently by HealthTree, this guide has been reviewed by CLL physician Adam Kittai, MD, Icahn School of Medicine at Mount Sinai, people with CLL, and CLL care partners to ensure relevance to you. 

Introduction

In this section, you will learn about the purpose of this guide, how to navigate it, and what you will need to search for elsewhere.

Understanding the Purpose of CLL Treatment

This section highlights the different types of CLL treatment and their purposes.

When Can I Start CLL Treatment?

This section dives into when patients will want to or need to start CLL treatment.

What are Common CLL Treatments?

This section dives into the different options for CLL treatment.

Considerations for Treatment Selection

This section contains information you should consider when deciding on a CLL treatment.

Benefits and Drawbacks of Standard CLL Therapies (1/2)

This section details the benefits and drawbacks of CLL therapies available for a fixed-duration.

Benefits and Drawbacks of Standard CLL Therapies (2/2)

This section contains the benefits and drawbacks of continuous-duration CLL therapies.

Other Factors That May Influence Treatment Decisions

This section describes other factors to take into consideration when deciding on a CLL treatment, such as CLL type, location of the disease, and more.

FDA-Approved Fixed-Duration Therapies for CLL

This section includes information on FDA-approved fixed-duration therapies for CLL treatment.

Venetoclax

This section describes venetoclax, an FDA-approved fixed-duration treatment for CLL.

Venetoclax and Monoclonal Antibody Combinations (1/3)

This section talks about monoclonal antibodies and their role in CLL treatment.

Venetoclax and Monoclonal Antibody Combinations (2/3)

This section describes the combination of venetoclax and obinutuzumab.

Venetoclax and Monoclonal Antibody Combinations (3/3)

This section described the combination of venetoclax and rituximab in CLL treatment.

How Effective are Venetoclax + Obinutuzumab?

This section talks about how well venetoclax and obinutuzumab work.

How Effective are Venetoclax + Rituximab?

This section explains how effective venetoclax + rituximab are.

How Effective is Venetoclax Retreatment?

Learn how effective venetoclax may be if you are retreated with it.

How Effective is Venetoclax After a BTK Inhibitor or Chemotherapy?

Learn how effective taking venetoclax is after a BTK inhibitor or chemotherapy.

CAR T-cell Therapy

This section details a one-time treatment for people with CLL, called CAR T-cell therapy. Learn about how effective it is and more.

FDA-Approved Continuous-Duration Therapies for CLL

This section details approved FDA treatments for CLL therapy that are continued until either the CLL progresses or the side effect burden becomes too severe.

BTK Inhibitors

This section defines BTK inhibitors and how they help treat CLL.

Ibrutinib

This section describes the BTK Inhibitor, ibrutinib, and how it works in CLL treatment.

Acalabrutinib

This section describes acalabrutinib, how it's administered, its efficacy, and more.

Zanubrutinib

Learn how zanubrutinib works, how effective it is in treating CLL, common side effects you may expect, and financial resources for this treatment.

Pirtobrutinib

This section details pirtobrutinib , a BTK inhibitor for CLL treatment, along with its administration, efficacy, and more.

Venetoclax by Itself

This section details venetoclax by Itself, which is a continuous-duration CLL therapy.

Side Effect Management of CLL Therapies

This section details the different side effects of CLL therapies and how to manage them.

Low Blood Cell Counts

This section details decreased cell counts, a side effect of CLL therapy, and how it is managed.

Infections

This section details infections, a side effect of CLL treatment, and how to manage it.

Gastrointestinal Side Effects

This section details Gastrointestinal side effects, a side effect of CLL therapy, and how to manage them.

Fatigue

This section details fatigue, a common side effect of CLL treatment, and how to manage it.

Muscle, Joint, and Bone Pain

This section details muscle, joint, and bone pain side effects of CLL therapies and how to manage them.

Bruising

This section details bruising, a side effect of CLL and CLL therapy, and how to manage it.

Tumor Lysis Syndrome

This section details tumor lysis syndrome, a rare side effect of CLL treatment, and how to manage it.

Cytokine Release Syndrome (CRS)

Learn about cytokine release syndrome (CRS), a side effect of CAR T-cell therapy.

Neurotoxicity and ICANS

Learn about brain-related side effects of CAR T-cell therapy.

CLL Patient and Specialist Perspectives on Treatments

This section details the perspectives of CLL patients and specialists on various fixed-duration and continuous-duration treatments.

Fixed-Duration Therapies Patient Perspective

This section details patient perspectives on fixed-duration CLL therapies.

Fixed-Duration Therapies Specialist Perspective

This section details specialists' explanations and perspectives on CLL fixed-duration therapies.

Continuous-Duration CLL Therapies Patient Perspective

This section details how patients feel about continuous-duration therapies for CLL.

Continuous-Duration Therapies Specialist Perspective

This section details how specialists feel about continuous-duration therapies for CLL.

A Look Ahead: The Future of CLL Treatment

This section highlights what the future could possibly hold for standard CLL treatments.

Improving Diagnosis

This section talks about how CLL diagnoses can be improved.

Advances in Treatment Strategies

This section details advances in treatment strategies for the potential future of CLL treatments.

The Future Role of Cell Therapy in CLL

This section details the future role of cell therapy in CLL.

Monitoring CLL and Relapse

This section details future monitoring of CLL and its relapse.

Addressing Mutations and Resistance

This section details the future of addressing mutations and resistance in CLL.

Inclusive Research and Treatment

This section details the future of research in CLL treatments.

Caregiver Role in CLL Treatment

This section details the role of a caregiver in CLL treatment.

Where Could a CLL Patient Need Support?

This section details how a CLL patient could need support from a caregiver during treatment.

Supportive Measures for Caregivers

This section details how CLL caregivers can receive support in their role.

Questions to Ask Your Doctor

This section details questions you can ask to discover which CLL treatments are right for you.

Financial Resources for CLL Treatments

This section details financial resources for CLL treatments.

Understanding Medicare Coverage for CLL

This section details typical medicare coverage for CLL treatments.

CLL Financial Resources from HealthTree

This section details the financial resources (including free coaching and webinars) that HealthTree Foundation provides for people with CLL and their loved ones.

Additional Resources

This section contains different resources and references from this CLL treatment guide.

HealthTree Resources

This section details references and resources from HealthTree for people with CLL and their loved ones.

External Resources

This section details external resources and references used in this guide that can support people with CLL and their loved ones.

Related Content